|
|
|
Volumn 41, Issue 1059, 1999, Pages 71-73
|
|
Rosiglitazone for type 2 diabetes mellitus
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACARBOSE;
ACETOHEXAMIDE;
CHLORPROPAMIDE;
GLIBENCLAMIDE;
GLIMEPIRIDE;
GLIPIZIDE;
HEMOGLOBIN A1C;
INSULIN;
METFORMIN;
MIGLITOL;
PIOGLITAZONE;
PLACEBO;
REPAGLINIDE;
ROSIGLITAZONE;
SULFONYLUREA DERIVATIVE;
TOLAZAMIDE;
TOLBUTAMIDE;
TROGLITAZONE;
UNCLASSIFIED DRUG;
BLOOD TOXICITY;
CLINICAL TRIAL;
DIABETES MELLITUS;
DIET;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG METABOLISM;
EXERCISE;
GASTROINTESTINAL TOXICITY;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
LIVER TOXICITY;
ORAL DRUG ADMINISTRATION;
SHORT SURVEY;
WEIGHT GAIN;
ADMINISTRATION, ORAL;
CLINICAL TRIALS;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN RESISTANCE;
SULFONYLUREA COMPOUNDS;
THIAZOLES;
THIAZOLIDINEDIONES;
|
|
EID: 0033551880
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (11)
|
|
References (0)
|